A Case from the Real World: Treating Advanced Melanoma as Part of the Interdisciplinary Team

---

ONLINE

Monday, October 14, 2024, 12:00 AM - Tuesday, October 14, 2025, 12:00 AM


AMA PRA Category 1 Credits™ (0.50 hours), ANCC - Nursing Contact Hour(s) (0.50 hours), Non-Physician Attendance (0.50 hours)

In the past decade, the treatment paradigm for advanced or metastatic melanoma has evolved. Most importantly, immunotherapy has enabled deep remissions for a significant fraction of patients, with approximately 10% needing no further melanoma therapy. Interdisciplinary clinicians involved in the management of patients with melanoma are often challenged to keep up with the therapy landscape and understand how to integrate new options in the treatment planning. Therefore, education is needed to help oncologists and other clinicians optimize the treatment plan for each patient based on the evolving clinical evidence, guideline recommendations, expert perspectives, and patient preferences and expectations for therapy.

1. Assess the role of immunotherapy in the care of patients with advanced melanoma.
2. Develop an interdisciplinary treatment plan for patients with advanced melanoma.
3. Manage adverse events associated with immunotherapy for advanced melanoma.
4. Leverage the skills of the interdisciplinary team members in the comprehensive care of patients with advanced melanoma.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designations: 
The University of Texas MD Anderson Cancer Center designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center designates this enduring material will award 0.50 Nursing Contact Hour(s).

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Supported by an independent educational grant from Bristol Myers Squibb.